Wu, Ziyan http://orcid.org/0000-0002-5243-6899
Li, Haolong
Xu, Honglin
Feng, Futai
Zhang, Fengchun
Zhang, Shulan
Wang, Li
Li, Yongzhe
Funding for this research was provided by:
the National Natural Science Foundation of China Grants (81871302, 81801631)
the National Key Research and Development Program of China (2018YFE0207300)
Beijing Municipal Science & Technology Commission (Z211100002521021)
the National High Level Hospital Clinical Research Funding (2022-PUMCH-B-124, 2022-PUMCH-A-007)
Article History
Received: 22 June 2023
Accepted: 17 August 2023
First Online: 15 September 2023
Declarations
:
: ZW, HL, HX, FF, FZ, SZ, LW, YL declare no conflicts of interest.
: The Ethics Committee of Peking Union Medical College Hospital approved the study protocol (JS-2156).
: The informed consent to participate in the ChIP-seq study was provided by the enrolled 3 PBC patients and 3 healthy controls or their families.